Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03994744
Recruitment Status : Recruiting
First Posted : June 21, 2019
Last Update Posted : August 28, 2019
Xiangya Hospital of Central South University
Innovent Biologics (Suzhou) Co. Ltd.
Information provided by (Responsible Party):
Lin Wu, Hunan Cancer Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : July 1, 2022